Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rina Sareli"'
Autor:
Hila Magen, Avichai Shimoni, Noga Shem-Tov, Arnon Nagler, Nira Varda-Bloom, Ronit Yerushalmi, Rina Sareli, Ivetta Danylesko
Publikováno v:
International Journal of Hematology. 114:363-372
Autologous stem cell transplantation (ASCT) is a standard of care in newly-diagnosed multiple myeloma (MM) patients. Several studies before the introduction of novel therapies in MM, demonstrated a pegylated G-CSF to be successful in mobilizing perip
Autor:
Ivetta, Danylesko, Rina, Sareli, Nira, Varda-Bloom, Ronit, Yerushalmi, Noga, Shem-Tov, Hila, Magen, Avichai, Shimoni, Arnon, Nagler
Publikováno v:
International journal of hematology. 114(3)
Autologous stem cell transplantation (ASCT) is a standard of care in newly-diagnosed multiple myeloma (MM) patients. Several studies before the introduction of novel therapies in MM, demonstrated a pegylated G-CSF to be successful in mobilizing perip
Autor:
Avichai Shimoni, Noga Shem-Tov, Ivetta Danylesko, Nira Bloom-Varda, Rina Sareli, Ronit Yerushalmi, Arnon Nagler
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:277-283
Human recombinant granulocyte colony-stimulating factor (G-CSF), filgrastim (Neupogen; Amgen, Thousand Oaks, CA, USA), has been widely used for the mobilization of CD34(+) hematopoietic stem cells (HSC) from healthy donors. The experience with biosim
Autor:
Nira Varda-Bloom, Noga Shem-Tov, Arnon Nagler, Ronit Yerushalmi, Avichai Shimoni, Ivetta Danylesko, Rina Sareli
Publikováno v:
Acta haematologica. 135(1)
Autologous hematopoietic stem cell transplantation is the standard therapy for refractory/relapsed aggressive lymphoma. The initial step of the procedure involves mobilization and collection of hematopoietic stem cells. G-CSF fails to achieve mobiliz
Autor:
Izhar Hardan, Shai Leipsiger, Ester Schallmach, Michal J. Besser, Jacob Schachter, Rina Sareli, Avraham J. Treves, Arnon Nagler
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 31(6)
Adoptive cell transfer represents an important mode of cancer immunotherapy and posttransplant associated viral infections. This technique involves massive volume reduction, as the procedure starts with large-scale ex vivo expansion of lymphocyte cul
Autor:
Avichai Shimoni, Rina Sareli, Yulia Volchek, Nira Bloom-Varda, Ivetta Danylesko, Arnon Nagler, Ronit Yerushalmi, Noga Shem-Tov
Publikováno v:
Blood. 122:3275-3275
Introduction Human recombinant G-CSF Filgrastim (Neupogen) has been widely used for the mobilization of CD34+ hematopoietic stem cells (HSC) from healthy donors. The experience with biosimilar G-CSF agents is limited and the only publication, to our